Comparative validity and responsiveness of PHQ-ADS and other composite anxiety-depression measures

Kurt Kroenke, Fitsum Baye, Spencer G. Lourens

Research output: Contribution to journalArticle

Abstract

Background: Composite measures that assess the overall burden of anxiety and depressive symptoms have been infrequently evaluated in the same study. The objective of this study was to compare the validity and responsiveness of the Patient Health Questionnaire Anxiety-Depression Scale (PHQ-ADS) and other composite anxiety-depression measures. Methods: The sample comprised 256 primary care patients enrolled in a telecare trial of chronic musculoskeletal pain and comorbid depression and/or anxiety. Measures included the PHQ-ADS; the 8-item and 4-item depression and anxiety scales from the PROMIS profiles; the PHQ-anxiety-depression scale (PHQ-4); the SF-36 Mental Health scale; and the SF-12 Mental Component Summary scale. Correlations among these measures and health-related quality of life measures were examined. Responsiveness was evaluated by standardized response means, area under the curve (AUC) analyses, and treatment effect sizes in the trial. Results: Convergent and construct validity was supported by strong correlations of the composite depression-anxiety measures with one another and moderate correlations with health-related quality of life measures, respectively. All composite measures differentiated patients who were better at 3 months, whereas the PHQ-ADS and PHQ-4 also distinguished the subgroup that had worsened. AUCs for composite measures were generally similar, whereas treatment effect sizes were largest for the PHQ-ADS. Limitations: The study sample was predominantly male veterans enrolled from primary care who had chronic musculoskeletal pain and moderate levels of depression and anxiety. Conclusions: Composite depression and anxiety scales are valid and responsive measures that may be useful as outcomes in research and clinical practice.

Original languageEnglish (US)
Pages (from-to)437-443
Number of pages7
JournalJournal of Affective Disorders
Volume246
DOIs
StatePublished - Mar 1 2019

Fingerprint

Anxiety
Depression
Health
Musculoskeletal Pain
Chronic Pain
Area Under Curve
Surveys and Questionnaires
Primary Health Care
Quality of Life
Veterans
Mental Health
Outcome Assessment (Health Care)
Therapeutics

Keywords

  • Anxiety
  • Depression
  • Measures
  • Psychometrics
  • Responsiveness
  • Validity

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Comparative validity and responsiveness of PHQ-ADS and other composite anxiety-depression measures. / Kroenke, Kurt; Baye, Fitsum; Lourens, Spencer G.

In: Journal of Affective Disorders, Vol. 246, 01.03.2019, p. 437-443.

Research output: Contribution to journalArticle

@article{d16645e90dde49239085e16e4c4b8cf7,
title = "Comparative validity and responsiveness of PHQ-ADS and other composite anxiety-depression measures",
abstract = "Background: Composite measures that assess the overall burden of anxiety and depressive symptoms have been infrequently evaluated in the same study. The objective of this study was to compare the validity and responsiveness of the Patient Health Questionnaire Anxiety-Depression Scale (PHQ-ADS) and other composite anxiety-depression measures. Methods: The sample comprised 256 primary care patients enrolled in a telecare trial of chronic musculoskeletal pain and comorbid depression and/or anxiety. Measures included the PHQ-ADS; the 8-item and 4-item depression and anxiety scales from the PROMIS profiles; the PHQ-anxiety-depression scale (PHQ-4); the SF-36 Mental Health scale; and the SF-12 Mental Component Summary scale. Correlations among these measures and health-related quality of life measures were examined. Responsiveness was evaluated by standardized response means, area under the curve (AUC) analyses, and treatment effect sizes in the trial. Results: Convergent and construct validity was supported by strong correlations of the composite depression-anxiety measures with one another and moderate correlations with health-related quality of life measures, respectively. All composite measures differentiated patients who were better at 3 months, whereas the PHQ-ADS and PHQ-4 also distinguished the subgroup that had worsened. AUCs for composite measures were generally similar, whereas treatment effect sizes were largest for the PHQ-ADS. Limitations: The study sample was predominantly male veterans enrolled from primary care who had chronic musculoskeletal pain and moderate levels of depression and anxiety. Conclusions: Composite depression and anxiety scales are valid and responsive measures that may be useful as outcomes in research and clinical practice.",
keywords = "Anxiety, Depression, Measures, Psychometrics, Responsiveness, Validity",
author = "Kurt Kroenke and Fitsum Baye and Lourens, {Spencer G.}",
year = "2019",
month = "3",
day = "1",
doi = "10.1016/j.jad.2018.12.098",
language = "English (US)",
volume = "246",
pages = "437--443",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",

}

TY - JOUR

T1 - Comparative validity and responsiveness of PHQ-ADS and other composite anxiety-depression measures

AU - Kroenke, Kurt

AU - Baye, Fitsum

AU - Lourens, Spencer G.

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Background: Composite measures that assess the overall burden of anxiety and depressive symptoms have been infrequently evaluated in the same study. The objective of this study was to compare the validity and responsiveness of the Patient Health Questionnaire Anxiety-Depression Scale (PHQ-ADS) and other composite anxiety-depression measures. Methods: The sample comprised 256 primary care patients enrolled in a telecare trial of chronic musculoskeletal pain and comorbid depression and/or anxiety. Measures included the PHQ-ADS; the 8-item and 4-item depression and anxiety scales from the PROMIS profiles; the PHQ-anxiety-depression scale (PHQ-4); the SF-36 Mental Health scale; and the SF-12 Mental Component Summary scale. Correlations among these measures and health-related quality of life measures were examined. Responsiveness was evaluated by standardized response means, area under the curve (AUC) analyses, and treatment effect sizes in the trial. Results: Convergent and construct validity was supported by strong correlations of the composite depression-anxiety measures with one another and moderate correlations with health-related quality of life measures, respectively. All composite measures differentiated patients who were better at 3 months, whereas the PHQ-ADS and PHQ-4 also distinguished the subgroup that had worsened. AUCs for composite measures were generally similar, whereas treatment effect sizes were largest for the PHQ-ADS. Limitations: The study sample was predominantly male veterans enrolled from primary care who had chronic musculoskeletal pain and moderate levels of depression and anxiety. Conclusions: Composite depression and anxiety scales are valid and responsive measures that may be useful as outcomes in research and clinical practice.

AB - Background: Composite measures that assess the overall burden of anxiety and depressive symptoms have been infrequently evaluated in the same study. The objective of this study was to compare the validity and responsiveness of the Patient Health Questionnaire Anxiety-Depression Scale (PHQ-ADS) and other composite anxiety-depression measures. Methods: The sample comprised 256 primary care patients enrolled in a telecare trial of chronic musculoskeletal pain and comorbid depression and/or anxiety. Measures included the PHQ-ADS; the 8-item and 4-item depression and anxiety scales from the PROMIS profiles; the PHQ-anxiety-depression scale (PHQ-4); the SF-36 Mental Health scale; and the SF-12 Mental Component Summary scale. Correlations among these measures and health-related quality of life measures were examined. Responsiveness was evaluated by standardized response means, area under the curve (AUC) analyses, and treatment effect sizes in the trial. Results: Convergent and construct validity was supported by strong correlations of the composite depression-anxiety measures with one another and moderate correlations with health-related quality of life measures, respectively. All composite measures differentiated patients who were better at 3 months, whereas the PHQ-ADS and PHQ-4 also distinguished the subgroup that had worsened. AUCs for composite measures were generally similar, whereas treatment effect sizes were largest for the PHQ-ADS. Limitations: The study sample was predominantly male veterans enrolled from primary care who had chronic musculoskeletal pain and moderate levels of depression and anxiety. Conclusions: Composite depression and anxiety scales are valid and responsive measures that may be useful as outcomes in research and clinical practice.

KW - Anxiety

KW - Depression

KW - Measures

KW - Psychometrics

KW - Responsiveness

KW - Validity

UR - http://www.scopus.com/inward/record.url?scp=85059147834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059147834&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2018.12.098

DO - 10.1016/j.jad.2018.12.098

M3 - Article

C2 - 30599366

AN - SCOPUS:85059147834

VL - 246

SP - 437

EP - 443

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

ER -